First CRISPR Gene Editing Treatment for Sickle Cell Disease

22 December 2023 NewsPublications

In the history of sickle-cell anaemia, UK and FDA approve gene therapy for the first time! It’s a real game changer! Check out the articles about it.

Vertex and CRISPR Therapeutics Announce Authorization of CASGEVY™

FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease

First gene editing therapy to treat beta thalassemia and severe sickle cell disease

UK first to approve CRISPR treatment for diseases: what you need to know (Nature)

CRISPR-Cas9 disease drug FDA gene therapy patient red blood cell sickle sickle cell disease